Jefferies Raises Price Target on Abbott (ABT)

Jefferies Raises Price Target on Abbott (ABT)

RSS

Jefferies reported on Tuesday that they have raised their price target for health care products company, Abbott Laboratories(ABT).

The firm, which currently has a “Buy” rating on ABT, has increased the company’s price target to $40. This price target suggests a 15% increase from the stock’s current price of $33.96.

Analysts have increased the company’s price target based on conservative guidance.

Abbott Laboratories shares were up 43 cents, or 1.28% during Tuesday morning trading. The stock has increased 23% in the past year.

The Bottom Line
Shares of Abbott Laboratories(ABT) have a 1.65% yield, based on Tuesday morning’s price of $33.96.

Abbott Laboratories(ABT) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from Dividend.com.

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today